Companies ordered by the number of approval records across the products that name them. Top 50 of 208 companies with a value; ties are broken by name. 418 of 443 approved products name at least one company (94%).
| # | Company | Approval records | Approved products |
|---|---|---|---|
| 1 | Roche / Genentech | 75 | 26 approved products |
| 2 | Pfizer (incl. Seagen) | 74 | 30 approved products |
| 3 | Novartis | 72 | 29 approved products |
| 4 | Bristol Myers Squibb | 66 | 26 approved products |
| 5 | AstraZeneca | 63 | 16 approved products |
| 6 | Merck & Co. (MSD) | 53 | 12 approved products |
| 7 | Johnson & Johnson | 41 | 15 approved products |
| 8 | Eli Lilly (incl. Loxo) | 38 | 13 approved products |
| 9 | Takeda | 29 | 11 approved products |
| 10 | Sanofi | 25 | 11 approved products |
| 11 | Ipsen | 23 | 7 approved products |
| 12 | Servier | 23 | 5 approved products |
| 13 | Amgen | 18 | 6 approved products |
| 14 | Bayer | 18 | 6 approved products |
| 15 | AbbVie (incl. ImmunoGen, Capstan) | 16 | 7 approved products |
| 16 | Daiichi Sankyo | 16 | 4 approved products |
| 17 | Astellas | 15 | 5 approved products |
| 18 | GSK | 15 | 7 approved products |
| 19 | Gilead Sciences (incl. Kite) | 14 | 4 approved products |
| 20 | Incyte | 14 | 4 approved products |
| 21 | Jazz Pharmaceuticals | 14 | 6 approved products |
| 22 | Genmab | 12 | 4 approved products |
| 23 | Natco Pharma | 12 | 4 approved products |
| 24 | Regeneron | 12 | 4 approved products |
| 25 | Jiangsu Hengrui Pharmaceuticals | 11 | 8 approved products |
| 26 | BeOne Medicines (formerly BeiGene) | 10 | 4 approved products |
| 27 | Boehringer Ingelheim | 10 | 4 approved products |
| 28 | Hetero Drugs | 10 | 2 approved products |
| 29 | Recordati | 10 | 5 approved products |
| 30 | Agilent Technologies (Dako) | 9 | 3 approved products |
| 31 | Chugai Pharmaceutical | 9 | 1 approved product |
| 32 | Eisai | 9 | 3 approved products |
| 33 | Halozyme Therapeutics | 9 | 3 approved products |
| 34 | Innovent Biologics | 8 | 4 approved products |
| 35 | Exelixis | 7 | 1 approved product |
| 36 | Betta Pharmaceuticals | 6 | 3 approved products |
| 37 | Myriad Genetics | 6 | 2 approved products |
| 38 | Acrotech Biopharma | 5 | 3 approved products |
| 39 | Akeso | 5 | 3 approved products |
| 40 | Bausch Health | 5 | 2 approved products |
| 41 | Kyowa Kirin | 5 | 2 approved products |
| 42 | Otsuka Pharmaceutical | 5 | 2 approved products |
| 43 | photonamic | 5 | 2 approved products |
| 44 | Sun Pharmaceutical Industries | 5 | 2 approved products |
| 45 | Taiho Pharmaceutical (Otsuka) | 5 | 2 approved products |
| 46 | Ferring Pharmaceuticals | 4 | 2 approved products |
| 47 | Guardant Health | 4 | 2 approved products |
| 48 | Hansoh Pharmaceutical | 4 | 2 approved products |
| 49 | Merck KGaA (EMD Serono) | 4 | 1 approved product |
| 50 | Novocure | 4 | 1 approved product |
158 more companies have a value below the top 50; the full list of companies is at /companies/.
Sums the approvals field over drug records with status approved whose companies field lists the company. A product with two companies (a partnership or an acquisition) counts in full for both. The context column counts those approved products. Supportive care medicines (antiemetics, growth factors, epoetins, bone-modifying agents, antidotes, opioids for cancer pain, immunoglobulin; drug records flagged supportive) are not products or treatments here and are left out.
Coverage. 418 of 443 approved products name at least one company (94%). Rows with a value of zero are not listed. Nothing is weighted, imputed or averaged; the ordering is by the number shown, then by name.
Machine-readable copy: /rankings/companies-by-approvals/data.json. Registry: src/lib/rankings.ts.